Zinc blocks gene expression of mitochondrial aconitase in human prostatic carcinoma cells

International Journal of Cancer

Volumn 118, Issue 3, 2006, Pages 609-615

  Tsui, Ke Hung ^a   Chang, Phei Lang ^a   Juang, Horng Heng ^a,b  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

Aconitase; Humic acid; Metal response element; Prostate; Zinc

Indexed keywords

ACONITATE HYDRATASE; ADENOSINE TRIPHOSPHATE; BETA GALACTOSIDASE; CHELATING AGENT; CITRIC ACID; COMPLEMENTARY DNA; DNA FRAGMENT; HUMIC ACID; LACTATE DEHYDROGENASE; LUCIFERASE; MITOCHONDRIAL ENZYME; PENTETIC ACID; ZINC; ZINC CHLORIDE;

ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; DNA PROTEIN COMPLEX; DNA SEQUENCE; ENZYME ASSAY; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MALE; MITOCHONDRION; PRIORITY JOURNAL; PROSTATE CARCINOMA;

ACONITATE HYDRATASE; ADENOSINE TRIPHOSPHATE; CHLORIDES; CITRATES; ELECTROPHORETIC MOBILITY SHIFT ASSAY; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MITOCHONDRIA; PROMOTER REGIONS (GENETICS); PROSTATIC NEOPLASMS; RESPONSE ELEMENTS; TUMOR CELLS, CULTURED; ZINC COMPOUNDS;

EID: 30444432209     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.21411     Document Type: Article

References (40)

1. Tapiero H, Tew KD. Trace elements in human physiology and pathology: zinc and metallothioneins. Biomed Pharmacother 2003;57:399-411.
2. Costello LC, Franklin RB. Novel role of zinc in the regulation of prostate citrate metabolism and its implication in prostate cancer. Prostate 1998;35:285-96.
3. Liang JY, Liu YY, Zou J, Franklin RB, Costello LC, Feng P. Inhibitory effect of zinc on human prostatic carcinoma cell growth. Prostate 1999;40:200-7.
4. Feng P, Liang JY, Guan ZX, Zou J, Franklin RB, Costello LC. Zinc induced mitochondria apoptogenesis in prostate cells. Mol Urol 2000;4:31-6.
5. Platz EA, Helzlsouer KJ, Hoffman SC, Morris JS, Baskett CK, Comstock GW. Prediagnostic toenail cadmium and zinc and subsequent prostate cancer risk. Prostate 2002;52:288-96.
6. Feng P, Li TL, Guan ZX, Franklin RB, Costello LC. Effect of zinc on prostatic tumorigenicity in nude mice. Ann NY Acad Sci 2003;1010:316-20.
7. Costello LC, Feng P, Milon B, Tan M, Franklin RB. Role of zinc in the pathogenesis and treatment of prostate cancer: critical issues to resolve. Prostate Cancer Prostatic Dis 2004;7:111-7.
8. Prasad AS, Kucuk O. Zinc in cancer prevention. Cancer Metastasis Rev 2002;21:291-5.
9. Leitzmann MF, Stampfer MJ, Wu K, Colditz GA, Willett WC, Giovannucci EL. Zinc supplement use and risk of prostate cancer. J Natl Cancer Inst 2003;95:1004-7.
10. Costello LC, Liu Y, Franklin RB, Kennedy MC. Zinc inhibition of mitochondrial aconitases and its importance in citrate metabolism of prostate epithelial cells. J Biol Chem 1997;272:28875-81.
11. Iguchi K, Hamatake M, Ishida R. Induction of necrosis by zinc in prostate carcinoma cells and identification of proteins increased in association with this induction. Eur J Biochem 1998;253:766-70.
12. Costello LC, Franklin RB, Liu Y, Kennedy MC. Zinc causes a shift toward citrate at equilibrium of the m-aconitase reaction of prostate mitochondria. J Inorg Biochem 2000;78:161-5.
13. Costello LC, Franklin RB. The intermediary metabolism of the prostate: a key to understanding the pathogenesis and progression of prostate malignancy. Oncology 2000;59:269-82.
14. Emptage MH, Kent TA, Kennedy MC, Beinert H, Munck E. Mossbauer and EPR studies of activated aconitases: development of a localized valence state at a subsite of the [4Fe-4S] cluster on binding of citrate. Proc Natl Acad Sci USA 1983;80:4674-8.
15. Juang HH. Modulation of mitochondrial aconitase on the bioenergy of human prostate carcinoma cells. Mol Genet Metab 2004;81:244-52.
16. Juang HH. Modulation of iron on mitochondrial aconitase expression in human prostatic carcinoma cells. Mol Cell Biochem 2004;265:185-94.
17. Tully DB, Collins BJ, Overstreet JD, Smith CS, Dinse GE, Mumtaz MM, Chapin RE. Effects of arsenic, cadmium, chromium, and lead on gene expression regulated by a battery of 13 different promoters in recombinant HepG2 cells. Toxicol Appl Pharmacol 2000;169:79-90.
18. Juang HH. Nitroprusside stimulates mitochondrial aconitase gene expression through the cyclic adenosine 3′,5′-monosphosphate signal transduction pathway in human prostate carcinoma cells. Prostate 2004;61:92-102.
19. Tsui KH, Chang PL, Lin HT, Juang HH. Down-regulation of prostate specific antigen promoter by p53 in human prostate cancer cells. J Urol 2004;172:2035-9.
20. Zaichick VY, Sviridova TV, Zaichick SV. Zinc concentration in human prostatic fluid: normal, chronic prostatitis, adenoma and cancer. Int Urol Nephrol 1996;28:687-94.
21. Guan Z, Kukoyi B, Feng P, Kennedy MC, Franklin RB, Costello LC. Kinetic identification of a mitochondrial zinc uptake transport process in prostate cells. J Inorg Biochem 2003;97:199-206.
22. Franklin RB, Ma J, Zou J, Guan Z, Kukoyi BI, Feng P, Costello LC. Human ZIP1 is a major zinc uptake transporter for the accumulation of zinc in prostate cells. J Inorg Biochem 2003;96:435-42.
23. Costello LC, Guan Z, Franklin RB, Feng P. Metallothionein can function as chaperone for zinc uptake transport into prostate and liver mitochondria. J Inorg Biochem 2004;98:664-6.
24. Henshall SM, Afar DE, Rasiah KK, Horvath LG, Gish K, Caras J, Ramakrishman V, Wong M, Jeffry U, Kench JG, Quinn DI, Turner JJ, et al. Expression of the zinc transporter ZnT4 is decreased in the progression from early prostate disease to invasive prostate cancer. Oncogene 2003;6005-12.
25. Untergasser G, Rumpold H, Plasm E, Witkowski M, Pfister G, Berger P. High levels of zinc ions induce loss of mitochondrial potential and degradation of antiapoptotic Bcl-2 protein in in vitro cultivated human prostate epithelial cells. Biochem Biophys Res Commun 2000;279:607-14.
26. Uzzo RG, Leavis P, Hatch W, Gabai VL, Dulin N, Zvartau N, Kolenko VM. Zinc inhibits nuclear factor-κB activation and sensitized prostate cancer cells to cytotoxic agents. Clin Cancer Res 2002;8:3579-83.
27. Chimienti F, Jourdan E, Favier A, Seve M. Zinc resistance impairs sensitivity to oxidative stress in HeLa cells: protection through metallothioneins expression. Free Radic Biol Med 2001;31:1179-90.
28. Chimienti F, Seve M, Richard S, Mathieu J, Favier A. Role of cellular zinc in programmed cell death: temporal relationship between zinc depletion, activation of caspases, and cleavage of Sp family transcription factors. Biochem Pharmacol 2001;62:51-62.
29. Feng P, Li TL, Guan ZX, Franklin RB, Costello LC. Direct effect of zinc on mitochondrial apoptogenesis in prostate cells. Prostate 2002;52:311-8.
30. Calace N, Petronio BM. The role of organic matter on metal toxicity and bio-availability. Ann Chim 2004;94:487-93.
31. Dineley KE, Votyakova TV, Reynolds IJ. Zinc inhibition of cellular energy production: implications for mitochondria and neurodegeneration. J Neurochem 2003;85:563-70.
32. Hasumi M, Suzuki K, Matsui H, Koike H, Ito K, Yamanaka H. Regulation of metallothionein and zinc transporter expression in human prostate cancer cells and tissue. Cancer Lett 2003;200:187-95.
33. Iguchi K, Otsuka T, Usui S, Ishii K, Onishi T, Sugimura Y, Hirano K. Zinc and metallothionein levels and expression of zinc transporter in androgen-independent subline of LNCaP cells. J Androl 2004;25:154-61.
34. Chen X, Agarwal A, Giedroc DP. Structural and functional heterogeneity among the zinc fingers of human MRE-binding transcription factor-1. Biochemistry 1998;37:1153-61.
35. Koizumi S, Suzuki K, Ogra Y, Yamada H, Otsuka F. Transcriptional activity and regulatory protein binding of metal-responsive elements of the human metallothionein-IIA gene. Eur J Biochem 1999;259:635-42.
36. Larchelle O, Stewart G, Moffatt P, Tremlay V, Seguin C. Characterization of the mouse metal-regulatory-element-binding proteins metal element protein-1 and metal regulatory transcription factor-1. Biochem J 2001;353:591-601.
37. Viarengo A, Burlando B, Ceratto N, Panfoli I. Antioxidant role of metallothioneins: a comparative overview. Cell Mol Biol 2000;46:407-17.
38. Yan Y, Sheppard PC, Kasper S, Lin L, Hoare S, Kapoor A, Dodd JG, Duckworth ML, Matusik RJ. Large fragment of the probasin promoter targets high levels of transgene expression to the prostate of transgenic mice. Prostate 1997;32:129-39.
39. Feng TH, Tsui KH, Juang HH. Cholesterol modulation of the expression of mitochondrial aconitase in human prostatic carcinoma cells. Chin J Physiol 2005;48:93-100.
40. Yoo HY, Chang MS, Rho HM. Heavy metal-mediated activation of the rat Cu/Zn superoxide dismutase gene via a metal-responsive element. Mol Gen Genet 1999;262:310-3.